Literature DB >> 24374662

Association of miR-502-binding site single nucleotide polymorphism in the 3'-untranslated region of SET8 and TP53 codon 72 polymorphism with non-small cell lung cancer in Chinese population.

Shaodi Yang1, Haiyan Guo, Benjie Wei, Shengcui Zhu, Yanlin Cai, Pei Jiang, Jianxin Tang.   

Abstract

The objective of this study was to identify whether the miR-502-binding site single nucleotide polymorphism (SNP) in the 3'-untranslated region (3'-UTR) of set domain-containing protein 8 (SET8) and the tumor protein p53 (TP53) codon 72 polymorphism were associated with the risk for non-small cell lung cancer (NSCLC), either independently or jointly, among Chinese people from southern Han. The genotypes of SET8 and TP53 codon 72 polymorphisms of peripheral blood DNA were detected using polymerase chain reaction-restriction fragment length polymorphism and direct DNA sequencing in a case-control study on 164 NSCLC cases and 199 controls. The SET8 TT (odds ratio, OR = 2.173, 95% confidence interval, CI = 1.0454.517) or TP53 GG (OR = 2.579, 95% CI = 1.366-4.870) genotype was associated with an increased risk of NSCLC by comparing with the SET8 CC or TP53 CC genotype, respectively. Similar results were obtained in SET8 recessive model (OR = 2.074, 95% CI = 1.019-4.221, P < 0.05), and the dominant and recessive model of TP53 codon 72 were performed, respectively (OR = 1.809, 95% CI = 1.159-2.825, P < 0.05; OR = 1.933, 95% CI = 1.096-3.409, P < 0.05). In addition, interaction between the SET8 and TP53 polymorphisms increased the risk of NSCLC in a multiply manner, with the OR being 3.032 (95%CI = 1.580-5.816) for subjects carrying both SET8 TT and TP53 GG genotypes. Therefore, the miR-502-binding site SNP in the 3'-UTR of SET8 and the TP53 codon 72 polymorphism may be markers of genetic susceptibility to NSCLC in Chinese population, and there is a possible gene-gene interaction in the incidence of NSCLC.

Entities:  

Keywords:  SET8; non-small cell lung cancer; polymorphism; tp53

Mesh:

Substances:

Year:  2013        PMID: 24374662     DOI: 10.1093/abbs/gmt138

Source DB:  PubMed          Journal:  Acta Biochim Biophys Sin (Shanghai)        ISSN: 1672-9145            Impact factor:   3.848


  12 in total

Review 1.  The TP53 codon 72 Pro/Pro genotype may be associated with an increased lung cancer risk in North China: an updated meta-analysis.

Authors:  Xin Wang; Li-Ran Hao; Kai Yue
Journal:  Int J Clin Exp Med       Date:  2015-03-15

Review 2.  Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials.

Authors:  Yuan Cheng; Cai He; Manni Wang; Xuelei Ma; Fei Mo; Shengyong Yang; Junhong Han; Xiawei Wei
Journal:  Signal Transduct Target Ther       Date:  2019-12-17

3.  Association of functional polymorphism at the miR-502-binding site in the 3' untranslated region of the SETD8 gene with risk of childhood acute lymphoblastic leukemia, a preliminary report.

Authors:  Mohammad Hashemi; Maryam Sheybani-Nasab; Majid Naderi; Fatemeh Roodbari; Mohsen Taheri
Journal:  Tumour Biol       Date:  2014-07-23

Review 4.  Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials.

Authors:  Yuan Cheng; Cai He; Manni Wang; Xuelei Ma; Fei Mo; Shengyong Yang; Junhong Han; Xiawei Wei
Journal:  Signal Transduct Target Ther       Date:  2019-12-17

5.  Polymorphism (rs16917496) at the miR-502 Binding Site of the Lysine Methyltransferase 5A (SET8) and Its Correlation with Colorectal Cancer in Iranians.

Authors:  Meysam Mosallayi; Miganoosh Simonian; Sharifeh Khosravi; Ahmad Reza Salehi; Mahsa Khodadoostan; Vahid Sebghatollahi; Azar Baradaran; Rasoul Salehi
Journal:  Adv Biomed Res       Date:  2017-07-14

6.  Gene Expression Analysis of Two Epithelial-mesenchymal Transition-related Genes: Long Noncoding RNA-ATB and SETD8 in Gastric Cancer Tissues.

Authors:  Nooshin Nourbakhsh; Modjtaba Emadi-Baygi; Rasoul Salehi; Parvaneh Nikpour
Journal:  Adv Biomed Res       Date:  2018-03-27

7.  The genomic landscape of undifferentiated embryonal sarcoma of the liver is typified by C19MC structural rearrangement and overexpression combined with TP53 mutation or loss.

Authors:  Bhuvana A Setty; Goodwin G Jinesh; Michael Arnold; Fredrik Pettersson; Chia-Ho Cheng; Ling Cen; Sean J Yoder; Jamie K Teer; Elsa R Flores; Damon R Reed; Andrew S Brohl
Journal:  PLoS Genet       Date:  2020-04-20       Impact factor: 5.917

Review 8.  Epi-miRNAs: Regulators of the Histone Modification Machinery in Human Cancer.

Authors:  Deniz Mortazavi; Behnoush Sohrabi; Meysam Mosallaei; Ziba Nariman-Saleh-Fam; Milad Bastami; Yaser Mansoori; Abdolreza Daraei; Sepideh Zununi Vahed; Shadan Navid; Zahra Saadatian; Tannaz Jamialahmadi; Yong Teng; Amirhossein Sahebkar
Journal:  J Oncol       Date:  2022-01-11       Impact factor: 4.375

9.  A functional single nucleotide polymorphism of SET8 is prognostic for breast cancer.

Authors:  Ben Liu; Xining Zhang; Fengju Song; Qun Liu; Hongji Dai; Hong Zheng; Ping Cui; Lina Zhang; Wei Zhang; Kexin Chen
Journal:  Oncotarget       Date:  2016-06-07

10.  The association between rs16917496 T/C polymorphism of SET8 gene and cancer risk in Asian populations: a meta-analysis.

Authors:  Hui-Xia Wei; Guo-Xiang Tian; Ju-Kun Song; Lian-Jie Yang; Yu-Pei Wang
Journal:  Biosci Rep       Date:  2018-11-13       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.